VAGINAL SQUAMOUS CELL CARCINOMA

Clinical trials for VAGINAL SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for VAGINAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope drug enters human testing for Tough-to-Treat cancers

Disease control Recruiting now

This is the first study in people testing a new drug called EVOLVE104. It aims to find a safe dose and see if it can help control advanced bladder and several types of squamous cell cancers. The study is for patients whose cancer has continued to grow despite standard treatments.

Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA

Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

VAGINAL SQUAMOUS CELL CARCINOMA

Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA trials appear

New hope drug enters human testing for Tough-to-Treat cancers